Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Peter Blackburn (6 out of 20 patents)

Stephen Grimes (5 out of 7 patents)

Tihamer Orban (1 out of 4 patents)

6 patents: Sort by Forward Citations

1. 12370251 - Adjuvanted nanoparticulate influenza vaccine (2025-07-29),

2. 11419924 - Immunotherapeutic compositions for the treatment of Alzheimer's disease (2022-08-23),

3. 11110155 - Immunotherapeutic compositions for the treatment of Alzheimer's disease (2021-09-07),

4. 10716836 - Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells (2020-07-21),

5. 10335468 - Immunotherapeutic compositions for the treatment of alzheimer's disease (2019-07-02),

6. 9498522 - Immunotherapeutic compositions for the treatment of alzheimer'S disease (2016-11-22),

Company Overview

Mercia Pharma, Inc. is a leading pharmaceutical company focused on developing and delivering innovative healthcare solutions to improve patients' quality of life. With a commitment to research and development, Mercia Pharma aims to address critical unmet medical needs and drive advancements in healthcare. The company's portfolio includes a range of products in various therapeutic areas, designed to meet the needs of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#1,027 in New York, NY

#2,693 in New York

#44,949 in US

New York, NY, United States of America

Mercia Pharma, Inc.

Forward Citations = 3

3 inventors:

Peter Blackburn (6 out of 20 patents)

Stephen Grimes (5 out of 7 patents)

Tihamer Orban (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mercia Pharma, Inc.. Retrieved from https://idiyas.com/company/mercia-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]